Mecklenburg Gabriel M.I. sold $14.0M of HNGE

Mecklenburg Gabriel M.I. sold 150,000 shares of Hinge Health, Inc. (HNGE) at an average of $93.22 ($88.98–$94.70, $13.98M total) across 6 trades on 2026-09-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mecklenburg Gabriel M.I.
Published Sep 15, 2026, 11:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 11:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HNGE
Bearish
high confidence
Mentioned
$HNGE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGEBearishMed
01

Why it matters

The disclosure provides fresh material for traders to reassess Hinge Health's valuation and insider sentiment.

02

Market read

Direct insider sell of $14M may trigger short-term price decline; traders should monitor price action.

03

What to watch

Potential tax planning or diversification motives; the 10b5-1 plan may have been pre-set.

Relevance 6/10Novelty 8/10Timing: post-market 2026-09-14

Background

Form 4 filing discloses insider transactions; director sells all holdings via a pre-arranged plan.

Company-level read

Ticker impact

$HNGEBearishHigh confidence
Context

Director Mecklenburg Gabriel M.I. sold all 150,000 shares for $13.98M via a 10b5-1 plan, leaving zero holdings.

Expected impact

Short-term downward pressure expected; traders may consider short positions or reduce exposure.

Evidence & confidence

The sale represents a large $14M disposition by an insider with no remaining stake, indicating possible negative outlook.

Market effects

May raise concerns for the digital health sector about insider confidence.

Limited to US markets where HNGE trades.

Low global impact; primarily affects Hinge Health investors.

Counterpoint

The sale could be a routine liquidity event unrelated to company fundamentals.

Key entities

  • Hinge Health, Inc.

    Digital health company providing musculoskeletal care platforms.

  • Mecklenburg Gabriel M.I.

    Director of Hinge Health who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.